News About United Kingdom

 

FREE BLOG Healthcare REIT interest ever stronger and unswayed by operator woes

Long leases and attractive yields are the cornerstones of healthcare real-estate which have greased the wheels of investments over the last 10-15 years. More healthcare-specialised funds are emerging now as laws open markets up to foreign capital and fund managers look to decrease investor risk.

First bids for dental chain expected before Christmas

A fast-growing UK dental chain has started a sales process with first bids expected before Christmas, multiple sources tell HBI. A source with knowledge of the sale says the group is looking for minority investment for growth, but there is speculation that for the right price, a majority stake could be on the table too.

Teleradiology fails to wow investors despite growth

The share price of Europe's largest teleradiology group by revenue, London-listed UK player Medica, is yet to recover from a post-IPO-boom trough for the last two years despite 15-20% growth and consistently high margins. We talk to new CEO Stuart Quin and an investment banking source about the jitters investors may have about the sector, including AI solutions eating its lunch.

UK real-estate investor acquires five nursing home sites

UK real-estate investor Barwood Capital has acquired five sites on which it intends to build nursing homes with a total of around 347 beds, which it claims will deliver over £55m (€64m) Gross Development Value (GDV).

Dentistry: At a tipping point for PE consolidators

Retail healthcare investors who have seen the European veterinary space undergo an eight-year period of rapid practice consolidation by private-equity backed groups are beginning to look at dentistry. Will yesterday's investors in vets tomorrow invest in dentists? HBI chats to Mansfield Advisors to find out more about how dentistry could be at a price tipping point that will favour big consolidators.

“Pens down” on UK deals before election

From psychiatric provider Priory Group, to nursing home group Four Seasons and PE-backed homecare company City & County Healthcare, HBI hears UK deals are off the cards until political certainty can be restored. We speak to advisers and enquire on the status of deals that could go ahead in the new year.

IDH looks set to sell next year – but could it sell even sooner?

There was speculation over the summer that the UK's biggest dental player by revenue, Mydentist (rebranded from IDH) was set to sell - and then all went quiet, drowned out in part by noise about Brexit and a possible election. But a sale is definitely on the cards next year and HBI hears rumours that investor Carlyle has been tentatively seeking earlier suitors for an accelerated exclusive bilateral deal before Christmas - though sources close to the company dismiss this suggestion out of hand.

Barchester to buy Four Seasons’ “jewel in the crown”

UK nursing home operator Barchester is reportedly in advanced talks to acquire 24 brighterkind homes, which were Four Seasons "jewel in the crown" before being carved off by owner Terra Firma. HBI considers the likely price and talks to a well-placed source to find out more.

Exclusive: SpaMedica pulled from sale as UK election and Brexit loom

The largest UK NHS cataract surgery provider, ophthalmic specialist SpaMedica, was pulled from sale recently after just a few weeks on the market and before bids could be submitted, HBI hears. But it could soon be back on the market, and HBI talks to three market experts to find out more about the aborted process, possible prices and suitors.

Exclusive: We name strategic buyer in talks to acquire BMI Healthcare

Independent sources tell HBI that UK hospital chain BMI Healthcare could soon be sold to another hospital operator by its landlord-turned-majority shareholder, just a year after it took over the business. We reveal the likely buyer, give the reaction of advisors and investors, and adjust BMI's likelihood of an imminent sale on HBI Intelligence Deals Pipeline tool to 95%.

FREE BLOG New HBI pipeline tool reveals long-held investments 

Nearly a third of all private equity-owned health care businesses in Europe have been held for at least five years, according to the new HBI Deals Pipeline tool. That suggests many private equity houses are struggling to sell on their investments.

Why UK specialist adult care is hotting up

Tough regulatory pressure, reputational risk and high profile scandals have put some operators off providing specialist adult care in the UK (which covers autism, learning disabilities and personality disorders). Yet interest from investors is hotting up and providers are growing rapidly. We speak to the head of healthcare at investment bank Alantra about opportunities on this market.

Four Seasons sale failure leaves long term future in doubt

The UK's largest nursing home group by revenue Four Seasons was set to sell 185 freehold properties to its creditor H/2 Capital Partners, but the sale fell through last week. If the US hedge fund doesn't take over, what does this mean for the future of the business, and where does it leave the operator? We speak to sources close to the deal.

Big teleradiology provider for sale as sector hots up

London-listed investment firm ICG is reportedly selling its UK-Australia teleradiology platform Everlight Radiology, while a Spanish diagnostics group recently entered the Latin American market with a small deal. The deals show two of the four cross-border teleradiology streams we have identified.

Exclusive: Change at the top at Unilabs

Jos Lamers, 55, the man widely seen as the architect of modern-day Unilabs is moving away from a full-time role at the Pan-European lab and imaging platform, HBI can exclusively reveal. So what lies behind the move and who succeeds him as CEO?

Advinia chairman hits back: We might leave the sector

The chairman and owner of UK nursing home group Advinia has lashed out at government watchdog the Care Quality Commission (CQC) as it examines the group's finances, exclusively telling HBI he may leave the sector completely unless it adopts a reasonable touch.

Fertility giant IVIRMA looking to sell minority stake

The largest fertility company in the world by revenue, Spanish-based IVIRMA, is looking for "an economic partner", with Morgan Stanley mandated to review strategic options. The most "optimistic" outcome, it says, would be the sale of a minority stake.

Find Us